Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. I: Structuring centers for the multidisciplinary clinical administration and management of CAR-T cell therapy patients

Chimeric antigen receptor T-cells (CAR-T cells) are a new modality of oncological treatment which has demonstrated impressive response in refractory or relapsed diseases, such as acute lymphoblastic leukemia (ALL), lymphomas, and myeloma but is also associated with unique and potentially life-threat...

Full description

Bibliographic Details
Main Authors: Diego V. Clé, Alexandre V. Hirayama, Alvaro J. Alencar, Luciano J. Costa, João V.P. Feliciano, Ederson R. Mattos, Ana C. Cordeiro, Marco Aurélio Salvino, George M. Navarro Barros, Marcos de Lima, Phillip Scheinberg, Renato L. Guerino-Cunha
Format: Article
Language:English
Published: Elsevier 2021-11-01
Series:Hematology, Transfusion and Cell Therapy
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2531137921001358